We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
As global criminals step up efforts to exploit the pandemic, Pfizer is combating the sale of counterfeit versions of its COVID-19 vaccines in Mexico and Poland. Read More
The FDA has granted priority reviews for two supplemental Biologics License Applications (sBLAs) by Seagen and Astellas Pharma for Padcev, their antibody-drug conjugate therapy for treating bladder cancer. Read More
In addition to its pact with GSK, CureVac has also partnered with Novartis and Bayer to potentially manufacture hundreds of millions of doses of CVnCoV. Read More
The FDA has approved Bristol Myers Squibb (BMS)’s Opdivo (nivolumab) in combination with chemotherapy as a first-line treatment for patients with gastric and esophageal cancers. Read More
The Centers for Disease Control and Prevention (CDC) will convene a second emergency meeting of its Advisory Committee on Immunization Practices at the end of the week to discuss the use of Johnson & Johnson (J&J)’s COVID-19 vaccine, following a delayed vote at its initial discussion on cases of very rare blood clots seen in vaccinated patients. Read More